fda and compound semaglutide says that the GLP-1 shortage is over Hims & Hers Health stock

Year-on-year (YoY) growth shows significant upward momentum, with market values increasing from USD 2,122.8 million in 2023 to USD 6,556.5 million in 2025, and continuing a steep rise over the forecast period

The FDA does not approve individual compounded medications the way it approves brand-name drugs, but 503A compounding pharmacies operate under strict federal and state regulations that ensure sterility, potency, and safety

Ozempic puede causar efectos secundarios graves, entre ellos: Inflamacin del pncreas (pancreatitis)

This is completely normal

For the first time in Medicares history, weight-loss drugs are on the table

Thoughtful I am so thankful for the Fridays team for my continued care